Immune stimulating and galectin-3 inhibitory effects of a hydrophilic polysaccharide nutraceutical from Tinospora cordifolia
Keywords:Tinospora cordifolia, immune stimulatio, T-cytotoxic cells, NK cells, galectin-3, gene expression
Tinospora cordifolia is an important ayurvedic herb known for its immune stimulating effect. In this investigation, we describe the galectin-3 inhibitory and immune stimulating properties of a novel water-soluble nutraceutical made from Tinospora cordifolia stem. This proprietary extract (T2CA) had a total yield of 6% and contained 86.9% carbohydrates with a high proportion of patented (1,4)-α-D-glucan in it. The T2CA activated T-cytotoxic and NK cells significantly contributing to its immune stimulating effect. Moreover, T2CA induced the activation of functional NK cells in human lymphocyte cultures that in turn contributed to the death of K562 leukemic cells in a dose-dependent manner in co-culture experiments. T2CA inhibited the expression of phosphorylated galectin-3 expression in human glioblastoma cell line which in turn inhibits the activity of MMP2 and MMP9 proteins in zymography investigations and inhibits migration of cancer cells in in vitro scratch assay. Western blot hybridization studies showed that T2CA downregulates the expression of total gal 3 proteins and extended the survival of AKR/J mice injected with Ehrlich ascites tumor cells in the Kepler-Meier survival curve analysis. The inhibitory effect of T2CA on phopho-galectin-3 expression and the activation of T-cytotoxic and NK cells suggested its protective effects against pathogenic infections and human malignancies via its immune stimulating mechanisms.
Smith HR, Heusel JW, Mehta IK, Kim S, Dorner BG, Naidenko OV et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci USA. 2002; 99: 8826-31.
Moser JM, Byers AM, Lukacher AE. NK cell receptors in antiviral immunity. Curr Opin Immunol. 2002; 14: 509-16.
Wajchman HJ, Pierce CW, Varma VA, Issa MM, Petros J, Dombrowski KE. Ex vivo expansion of CD8+CD56+ and CD8+CD- natural killer T cells specific for MUC1 mucin. Cancer Res. 2004; 64: 1171-80.
Hackett CJ. Innate immune activation as a broad-spectrum biodefense strategy: prospects and research challenges. J Allergy Clin Immunol. 2003; 112: 686-94.
Boscher C, Dennis JW, Nabi IR. Glycosylation, galectins and cellular signaling. Curr Opin Cell Biol. 2011; 23: 383- 92.
Liu FT, Rabinovich GA. Galectins as modulators of tumor progression. Nature Reviews Cancer. 2005; 5: 29-41.
Yamaoka K, Ohno S, Kawasaki H, Suzuki K. Overexpression of a beta-galactoside binding protein causes transformation of BALB3T3 fibroblast cells. Biochem Biophys Res Commun. 1991; 179: 272-79.
Inohara H, Raz A. Functional Evidence That Cell-Surface Galectin-3 mediates homotypic cell-adhesion. Cancer Res. 1995; 55: 3267-71.
Kim SJ, Shin JY, Lee KD, Bae YK, Choi IJ, Park SH et al. Galectin-3 facilitates cell motility in gastric cancer by up-regulating protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1). PLoS One. 2011; 6: e25103. doi: 10.1371/journal.pone.0025103.
Takenaka Y, Inohara H, Yoshii T, Oshima K, Nakahara S, Akahani S, et al. Malignant transformation of thyroid follicular cells by galectin-3. Cancer Lett. 2003; 195: 111-9.
Radosavljevic G, Jovanovic I, Majstorovic I, Mitrovic M, Lisnic VJ, Arsenijevic N, et al. Deletion of galectin-3 in the host attenuates metastasis of murine melanoma by modulating tumor adhesion and NK cell activity. Clin Exp Metastasis. 2011; 28: 451-62.
Nangia-Makker P, Honjo Y, Sarvis R, Akahani S, Hogan V, Pienta KJ, et al. Galectin-3 induces endothelial cell morphogenesis and angiogenesis. Am J Pathol. 2000; 156: 899-909.
Fukumori T, Kanayama HO, Raz A: The role of galectin-3 in cancer drug resistance. Drug Resist Update. 2007; 10: 101-8.
Lurisci I, Tinari N, Natoli C, Angelucci D, Cianchetti E, Iacobelli S et al. Concentrations of galectin-3 in the sera of normal controls and cancer patients. Clin Cancer Res. 2000; 6: 1389-93.
Chopra RN, Chopra IC, Handa KD, Kanpur LD. editors. Glossary of Indian medicinal plants. Indian Council of Scientific and Industrial Research, New Delhi, 1982.
Nair PKR, Rodriguez S, Ramachandran R, Alamo A, Melnick SJ, Escalon E, et al. Immune stimulating properties of a novel polysaccharide form the medicinal plant Tinospora cordifolia. Int Immunopharmacol. 2004; 4:1645-59.
Nair PKR, Melnick SJ, Ramachandran R, Escalon E, Ramachandran C. Mechanism of macrophage activation by (1,4)-α-D-glucan isolated from Tinospora cordifolia. Int Immunopharmacol. 2006; 6: 1815-24.
Ramachandran C, Lollett IV, Escalon E. Quirin KW, Melnick SJ. Anticancer potential and mechanism of action of mango ginger (Curcuma amada Roxb.) supercritical CO2 extract in human glioblastoma cells. J Evid Based Complementary Altern Med. 2014; 20:109–19.
Ramachandran C, Wilk BJ, Hotchkiss A Chau H, Eliaz I, Melnick SJ. Activation of human T-helper/Inducer cell, T-cytotoxic cell, B-cell, and natural killer (NK) cells and induction of natural killer cell activity against K562 chronic myeloid leukemia cells with modified pectin. BMC Complement Altern Med. 2011; 11: 59 doi: 10.1186/1472-6882-11-59.
Liu L, Chahroudi A, Silvestri G, Wernett ME, Kaiser WJ, Safrit JT, et al. Visualization and quantitation of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase molecules. Nat Med. 2000, 8: 185-9.
Jerome Kr, Sloan DD, Albert M. Measuring T-cell mediated cytotoxicity using antibody to activated caspase. Nat Med. 2002, 9: 4-5.
Ramachandran C, Juan A, Quirin K-W, Khatib L, Escalon E, Khatib Z, et al. Anticancer and antimetastatic effects of supercritical extracts of hops (Humulus lupulus L.) and mango ginger (Curcuma amada Roxb.) in human glioblastoma. Int J Phytomed. 2018; 10: 191-200.
Toth M, Fridman R. Assessment of gelatinases (MMP-2 and MMP-9) by gelatin zymography. Methods Mol Med. 2012; 878:121–35.
Liang CC, Park AY, Guan JL. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc. 2007; 2: 329-33.
Ramachandran C, Portalatin G, Prado A, Quirin K-W, Escalon E, Melnick SJ. In vivo antitumor effect of supercritical CO2 extract of mango ginger (Curcuma amada Roxb) in U87-MG human glioblastoma nude mice xenografts. J Evid Based Complementary Atern Med. 2017; 22: 260-67.
Ramachandran C, Quirin KW, Escalon E, Lollett IV, Melnick SJ. Therapeutic effect of supercritical CO2 extracts of Curcuma species with cancer drugs in rhabdomyosarcoma cell lines. Phytother Res. 2015; 8:1152-60.
Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990; 61:759-67.
Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet. 1993; 9:138-41
Jakóbisiak M, Lasek W, Gołab J. Natural mechanisms protecting against cancer. Immunol Lett. 2003; 90:103-22.
Pahl J, Cerwenka A. Tricking the balance: NK cells in anti-cancer immunity. Immunobiology. 2017; 222: 11-20.
Cerwenka A, Lanier LL. Natural killer cell memory in infection, inflammation and cancer. Nat Rev Immunol. 2016; 16:112-23.
Robertson MJ and Ritz J. Biology and clinical relevance of natural killer cells. Blood. 1990; 76: 2421-38.
Takeda K, Okumura. CAM and NK cells. eCAM. 2010; 1: 17-27.
Zou J, Glinsky VV, Landon LA, Matthews L, Deutscher SL. Peptides specific to the galectin-3 carbohydrate recognition domain inhibit metastasis-associated cancer cell adhesion. Carcinogenesis. 2005; 26: 309-18.
Califice S, Castronovo V, Van Den Brule F. Galectin-3 and cancer (Review). Int J Oncol. 2004; 25: 983–92.
Dumic J, Dabelic S, Flogel M. Galectin-3: an open-ended story. Biochim Biophys Acta. 2006; 1760: 616-35.
Kim SJ, Lee HW, Gu Kang H, La SH, Choi IJ, Ro JY, et al. Ablation of galectin-3 induces p27 (KIP1)- dependent premature senescence without oncogenic stress. Cell Death Differ. 2014; 21:1769-79.
Wang Y, Balan V, Kho D, Hogan V, Nangia-Makker P, Raz A. Galectin-3 regulates p21 stability in human prostate cancer cells. Oncogene. 2013; 32: 5058-65.
Stewart CJ, Crook ML. Galectin-3 expression in uterine endometrioid adenocarcinoma: comparison of staining in conventional tumor glands and in areas of MELF pattern myometrial invasion. Int J Gynecol Pathol. 2010; 29: 555–61.
Leal MF, Calcagno DQ, Chung J, de Freitas VM, Demachki S, Assumpção PP, et al. Deregulated expression of annexin-A2 and galectin-3 is associated with metastasis in gastric cancer patients. Clin Exp Med. 2014; 15: 415-20.
Gillenwater A, Xu XC, el-Naggar AK, Clayman GL, Lotan R. Expression of galectins in head and neck squamous cell carcinoma. Head Neck. 1996; 18: 422-32.
Ochieng J, Furtak V, Lukyanov P. Extracellular functions of galectin-3. Glycoconj J. 2004; 19: 527-35.
Yamaki S, Fujii T, Yajima R, Yamaguchi S, Fujisawa T, Tsutsumi S, et al. Clinicopathological significance of decreased galectin-3 expression and the long-term prognosis in patients with breast cancer. Surg Today. 2013; 43: 901-5.
Kidd P. Th1/Th2 balance: The hypothesis, its limitations and implications for health and disease. Altern Med Review. 2003; 8: 225-46
Dumont F. Modulation of Th1 and Th2 responses for immunotherapy. Expert Opin Therap patents. 2005; 12: 341-67.
Farhad M, Rolig AS, Redmond WL. The role of Galectin-3 in modulating tumor growth and immunosuppression within the tumor microenvironment. OncoImmunology. 2018; 7: 6, e1434467, doi: 10.1080/2162402X.2018.1434467.
Yang RY, Hsu DK, Liu FT. Expression of galectin-3 modulates T cell growth and apoptosis. Proc Natl Acad Sci USA. 1996; 93: 6737-42
Anderson KG, Stromnes IM, Greenberg PD. Obstacles posed by the tumor microenvironment to T cell Activity: A case for synergistic therapies. Cancer Cell. 2017; 31: 311-25.
Chen HY, Fermin A, Vardhana S, Weng IC, Lo KF, Chang EY, et al. Galectin-3 negatively regulates TCR-mediated CD4C T-cell activation at the immunological synapse. Proc Natl Acad Sci U S A. 2009; 106: 14496-501.